NRAP reduction rescues sarcomere defects in nebulin-related nemaline myopathy
Human Molecular Genetics · 2023
DOI: 10.1093/hmg/ddad011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, 2023. Verfasst von Jennifer G Casey und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Myopathies, Nemaline. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, National Institutes of Health, Innovation Evergreen Fund.
Abstract (Originalsprache)
Nemaline myopathy (NM) is a rare neuromuscular disorder associated with congenital or childhood-onset of skeletal muscle weakness and hypotonia, which results in limited motor function. NM is a genetic disorder and mutations in 12 genes are known to contribute to autosomal dominant or recessive forms of the disease. Recessive mutations in nebulin (NEB) are the most common cause of NM affecting about 50% of patients. Because of the large size of the NEB gene and lack of mutational hot spots, developing therapies that can benefit a wide group of patients is challenging. Although there are several promising therapies under investigation, there is no cure for NM. Therefore, targeting disease modifiers that can stabilize or improve skeletal muscle function may represent alternative therapeutic strategies. Our studies have identified Nrap upregulation in nebulin deficiency that contributes to structural and functional deficits in NM. We show that genetic ablation of nrap in nebulin deficiency restored sarcomeric disorganization, reduced protein aggregates and improved skeletal muscle function in zebrafish. Our findings suggest that Nrap is a disease modifier that affects skeletal muscle structure and function in NM; thus, therapeutic targeting of Nrap in nebulin-related NM and related diseases may be beneficial for patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
- Department of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ 85724, USA.
ORCID-Profile: Vandana A Gupta
Förderung
- NIAMS NIH HHS
- National Institutes of Health
- Innovation Evergreen Fund
Zitieren
APA
Casey, J. G., Kim, E. S., Joseph, R., Li, F., Granzier, H., & Gupta, V. A. (2023). NRAP reduction rescues sarcomere defects in nebulin-related nemaline myopathy. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddad011
Vancouver
Casey JG, Kim ES, Joseph R, Li F, Granzier H, Gupta VA. NRAP reduction rescues sarcomere defects in nebulin-related nemaline myopathy. Human Molecular Genetics. 2023. doi:10.1093/hmg/ddad011
BibTeX
@article{Casey2023,
author = {Casey, Jennifer G and Kim, Euri S and Joseph, Remi and Li, Frank and Granzier, Henk and Gupta, Vandana A},
title = {NRAP reduction rescues sarcomere defects in nebulin-related nemaline myopathy},
journal = {Human Molecular Genetics},
year = {2023},
doi = {10.1093/hmg/ddad011}
}
EUVIMED